New SEC Form D filing
Argonaute RNA Ltd, 2026-09-24
A new SEC Form D private-offering notice from Cardiff, a $1,800,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Develops RNA interference therapeutics using proprietary siRNA platforms for cardiometabolic diseases
Filed 2026-09-24Filed to raise $1,800,000First money in 2026-09-09Raised so far $1,800,000HQ (as filed) CardiffSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified argonauterna.com↗Named in the filing 9 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- AutoIVF, Inc., 2026-09-25, $1.5M, Natick, MA
- Dignify Therapeutics, LLC, 2026-09-25, $3M, Research Triangle Park, NC
- EnteroTrack, LLC, 2026-09-25, $2M, Aurora, CO
- Swift Cardiovascular, Inc., 2026-09-24, $1.5M, Durham, NC
- Seraxis Holdings, Inc., 2026-09-24, $10M, Germantown, MD
- Uvantis Therapeutics, Inc., 2026-09-23, $5M, Columbia, MD
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.